TSNAX

Translin-associated protein X · Q99598 · TSNAX on Sugi Atlas →

0 patent compounds predicted against TSNAX, 0 high-confidence (nearest known ligand ≥ 0.5)

Top predicted compounds (top 20 by supporting neighbours, then confidence)

CompoundConfidenceSupporting neighbours

Clinical trials — most relevant to TSNAX by text similarity (a relevance ranking, not an exhaustive list)

TrialPhaseStatus
A Study of KRN23 in Pediatric Patients With X-linked Hypophosphatemic Rickets/Osteomalacia PHASE3COMPLETED
Tianasen (ASO-GNAO1) for GNAO1-Encephalopathy With Epilepsy and Movement Disorders. PHASE1/PHASE2RECRUITING
Reverse Transcriptase Inhibitors in AGS PHASE2COMPLETED
Safety and Efficacy of Etravirine in Friedreich Ataxia Patients PHASE2COMPLETED
An Open-Label Trial of Donepezil in Fragile X Syndrome PHASE1COMPLETED
Evaluation of the Safety and Efficacy of BBM-D101 to Treat Patients with Duchenne Muscular Dystrophy EARLY_PHASE1RECRUITING
Turner Syndrome: Genotype and Phenotype nanCOMPLETED
MiRNA223 and HMGB1 as Apredictos for Drug Resistant Epilepsy nanUNKNOWN
Better Delineation of DDX3X Related Phenotype and Epigenetic Signature. nanUNKNOWN
Autophagy in Systemic Lupus Erythematosus nanUNKNOWN
Thymidylate Synthase Polymorphisms as a Predictor of Toxicity to 5-Fluorouracil Based Chemotherapy in Stage III Colon Cancer nanUNKNOWN
DDX3X Syndrome -The Seaver Autism Center for Research and Treatment is Characterizing DDX3X-related Neurodevelopmental Disorders Using Genetic, Medical, and Neuropsychological Measures. nanCOMPLETED
A Clinical Study on the Efficacy and Safety of Methotrexate (MTX) or Thiotepa (for MTX Intolerance) or Temozolomide (TMZ) Combined With Orelabrutinib and Selinexor in Relapsed/Refractory Primary or Secondary Central Nervous System Lymphoma(SELINA) nanRECRUITING
Treatment of Chronic Lymphocytic Leukemia nanUNKNOWN
Genomic Translation for Amyotrophic Lateral Sclerosis Care nanCOMPLETED
Serum Betatrophin Levels and Its Influencing Factors in Patients With Hyperthyroidism nanUNKNOWN
Improvement of DIAgnostic and Phenotype-genotype Correlation Studies in Patients With MYOpathy Suspected of TITinopathy nanUNKNOWN
X-chromosome Inactivation, Epigenetics and the Transcriptome nanCOMPLETED
Clinical Manifestations and Biomarkers in Amyotrophic Lateral Sclerosis Type 4 and Other Inherited Neurological Disorders of RNA Processing nanRECRUITING
Collection of Blood Samples for DNA in Motor Neuron Disease nanCOMPLETED
Neural Biomarkers in Fragile X Syndrome nanCOMPLETED
Amyotrophic Lateral Sclerosis (ALS) Families Project nanRECRUITING
Corpus Callosum Agenesis and Intellectual Disability nanCOMPLETED
The Danish TURNER Cryopreservation Study nanRECRUITING
Identification of New FTLD Genes nanUNKNOWN
Prevalence of a Non-Expressing 11B Mutation in Aka Peoples of the Central African Republic nanCOMPLETED
Endolymphatic Sac Tumors in a Population of Patients With Von Hippel-Lindau Disease:The Natural History and Pathobiology, and a Prospective Non-Randomized Clinical Trial of Hearing Preservation Surgery in Patients With Early Stage Endolymphatic Sac Tumors nanCOMPLETED
A Dose-escalation Trial of Stereotactic Ablative Body Radiotherapy for Non-spine Bone & Lymph Node Oligometastates nanCOMPLETED
Whole-genome Sequencing Study in Patients With Diminished Ovarian Reserve nanUNKNOWN
miRNA as a Growth Plate Marker After GH nanUNKNOWN

Related proteins — ESM-2 sequence neighbours (a TSNAX binder may also engage these)

ProteinNameSimilarity
Q5RC21 1.000 Q5RC21 →
Q4R599 1.000 Q4R599 →
Q9JHB5 1.000 Q9JHB5 →
Q9QZE7 0.997 Q9QZE7 →
Q9DBA9 0.974 Q9DBA9 →
P32780 0.973 P32780 →
Q5R981 0.973 Q5R981 →
Q00004 0.973 Q00004 →
Q8N1G2 0.972 Q8N1G2 →
Q9XHM1 0.971 Q9XHM1 →
P79769 0.971 P79769 →
O49160 0.971 O49160 →
UFL1 E3 UFM1-protein ligase 1 0.971 landscape →
SRP68 Signal recognition particle subunit SRP68 0.971 landscape →
A1A4I9 0.971 A1A4I9 →
Q66HC5 0.971 Q66HC5 →
Q99P88 0.970 Q99P88 →
F4IDS7 0.970 F4IDS7 →
Q6GQ80 0.970 Q6GQ80 →
Q9UPM8 0.970 Q9UPM8 →
NUP155 Nuclear pore complex protein Nup155 0.970 landscape →
Q9DBC3 0.969 Q9DBC3 →
A5PJZ5 0.969 A5PJZ5 →
Q8CCJ3 0.969 Q8CCJ3 →
Q5U2Z5 0.969 Q5U2Z5 →
Q4R367 0.969 Q4R367 →
Q8BJ71 0.969 Q8BJ71 →
P37199 0.969 P37199 →
Q5ZJX5 0.968 Q5ZJX5 →
Q9LL84 0.968 Q9LL84 →